(Q39457319)

English

Arsenic trioxide therapy in relapsed or refractory Japanese patients with acute promyelocytic leukemia: updated outcomes of the phase II study and postremission therapies

scientific article published on October 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Arsenic trioxide therapy in relapsed or refractory Japanese patients with acute promyelocytic leukemia: updated outcomes of the phase II study and postremission therapies (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

arsenic trioxide

0 references

acute promyelocytic leukemia

1 reference

based on heuristic

inferred from title

author name string

Kazuyuki Shigeno

1

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Kensuke Naito

2

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Naohi Sahara

3

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Miki Kobayashi

4

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Satoki Nakamura

5

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Sinya Fujisawa

6

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Kaori Shinjo

7

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Akihiro Takeshita

8

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Ryuzo Ohno

9

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Kazunori Ohnishi

10

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 October 2005

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

International Journal of Hematology

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

82

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

224-229

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

https://scigraph.springernature.com/pub.10.1532/ijh97.05044

0 references

Herpes zoster during treatment with arsenic trioxide

1 reference

https://pubmed.ncbi.nlm.nih.gov/16207595

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment with a new synthetic retinoid, Am80, of acute promyelocytic leukemia relapsed from complete remission induced by all-trans retinoic acid

1 reference

https://pubmed.ncbi.nlm.nih.gov/16207595

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of prognostic factors in newly diagnosed acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Japan Adult Leukemia Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/16207595

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prolongation of the QT interval and ventricular tachycardia in patients treated with arsenic trioxide for acute promyelocytic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/16207595

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Studies on treatment of acute promyelocytic leukemia with arsenic trioxide: remission induction, follow-up, and molecular monitoring in 11 newly diagnosed and 47 relapsed acute promyelocytic leukemia patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/16207595

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Huang ME, Ye YC, Chen SR, et al. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood. 1988;72(2):567-572

1 reference

https://pubmed.ncbi.nlm.nih.gov/16207595

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/16207595

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/16207595

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multi-institutional study of all-trans-retinoic acid as a differentiation therapy of refractory acute promyelocytic leukemia. Leukaemia Study Group of the Ministry of Health and Welfare

1 reference

https://pubmed.ncbi.nlm.nih.gov/16207595

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New retinoids and arsenic compounds for the treatment of refractory acute promyelocytic leukemia: clinical and basic studies for the next generation

1 reference

https://pubmed.ncbi.nlm.nih.gov/16207595

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

History of the development of arsenic derivatives in cancer therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/16207595

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results

1 reference

https://pubmed.ncbi.nlm.nih.gov/16207595

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcription factor, PML

1 reference

https://pubmed.ncbi.nlm.nih.gov/16207595

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Arsenic trioxide therapy for relapsed or refractory Japanese patients with acute promyelocytic leukemia: need for careful electrocardiogram monitoring

1 reference

https://pubmed.ncbi.nlm.nih.gov/16207595

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of bone marrow transplantation in acute promyelocytic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/16207595

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide

1 reference

https://pubmed.ncbi.nlm.nih.gov/16207595

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus

1 reference

https://pubmed.ncbi.nlm.nih.gov/16207595

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

All-trans retinoic acid therapy in relapsed/refractory or newly diagnosed acute promyelocytic leukemia (APL) in Japan

1 reference

https://pubmed.ncbi.nlm.nih.gov/16207595

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autologous and allogeneic stem-cell transplantation as salvage treatment of acute promyelocytic leukemia initially treated with all-trans-retinoic acid: a retrospective analysis of the European acute promyelocytic leukemia group

1 reference

https://pubmed.ncbi.nlm.nih.gov/16207595

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/16207595

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

All-trans retinoic acid for the treatment of newly diagnosed acute promyelocytic leukemia. Japan Adult Leukemia Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/16207595

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long QT syndrome and torsade de pointes in a patient receiving fluconazole

1 reference

https://pubmed.ncbi.nlm.nih.gov/16207595

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic stem cell transplantation for advanced acute promyelocytic leukemia: results in patients treated in second molecular remission or with molecularly persistent disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/16207595

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1532/IJH97.05044

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Dimensions Publication ID

0 references

release_pe66sqinhjh5lcutoegy57j7zm

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39457319&oldid=1829151402"